retatrutide developer eli lilly Strengthens Its Weight Loss Pipeline. Why Could Be the Next Growth Driver for LLY 🎥 Eli Lilly’s next generation

Eli Lilly previously said that phase three study was expected to finish in February 2026

This is really a cardiologist issue

This is relevant because muscle-related concerns with tirzepatide are common, and understanding how BMI category affects body composition changes helps set appropriate expectations

Just when you thought you knew what to expect with GLP-1s, new research emerges that gives you pause

Aim for at least 64 ounces (8 cups) daily, more if you're increasing fiber intake

The proportion of patients with PCOS who were prescribed semaglutide or tirzepatide increased more than 7-fold over the study period